Biotechnology

Cardio Diagnostics

Cardio Diagnostics released FY2025 9 Months earnings on November 12 (EST), actual revenue USD 11.27 K, actual EPS USD -2.9129

Cardio Diagnostics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 2.855 K (forecast USD 150 K), actual EPS USD -0.9753 (forecast USD -1.8)

Cardio Diagnostics Holdings Expands Provider Network

Cardio Diagnostics released FY2025 Q2 earnings on August 14, 2025, EST: Actual Revenue USD 7.475 K (Forecast USD 75 K), Actual EPS USD -0.9678 (Forecast USD -1.8)

Cardio Diagnostics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 8.415 K, actual EPS USD -1.9373

Cardio Diagnostics and AGEPHA Partner on CHD Precision Management Study

Cardio Diagnostics Holdings Obtains Patent for Cardiovascular Disease Detection

Cardio Diagnostics Holdings Inc. Expanding Precision Cardiovascular Care Partnerships

Cardio Diagnostics Holdings Q1 Loss of $1.80 Expected

Cardio Diagnostics released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 940 (forecast USD 50K), actual EPS USD -0.9697 (forecast USD -1.8)

Cardio Diagnostics Holdings Inc forecasts a loss of 6 cents per share and a 213.9% revenue growth

Cardio Diagnostics released FY2024 Annual Earnings on March 20 (EST), actual revenue USD 34.89 K (forecast USD 55 K), actual EPS USD -9.3521 (forecast USD -10.8)

Cardio Diagnostics released FY2024 Q4 earnings on March 20 (EST), actual revenue USD 4.512 K (forecast USD 25 K), actual EPS USD -1.1561 (forecast USD -1.8)

Cardio Diagnostics Forms Strategic Partnership with Seven Medical Service Institutions in Chicago

Cardio Diagnostics released FY2024 9 Months Earnings on November 13 (EST), actual revenue USD 30.38K, actual EPS USD -9.369

Cardio Diagnostics released FY2024 Q3 earnings on November 13 (EST), actual revenue USD 6.58 K (forecast USD 10 K), actual EPS USD -1.7337 (forecast USD -1.5)

Cardio Diagnostics released FY2024 Q2 earnings on August 12 (EST), actual revenue USD 7.87 K (forecast USD 100 K), actual EPS USD -1.7091 (forecast USD -2.7)

Cardio Diagnostics released FY2024 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 23.8K and EPS of USD -7.4876

Cardio Diagnostics released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 15.93 K (forecast USD 25 K), actual EPS USD -5.9261 (forecast USD -2.7)

Cardio Diagnostics released FY2023 Q4 earnings on April 1 (EST), actual revenue USD 5.31 K (forecast USD 125 K), actual EPS USD -2.1905 (forecast USD -4.05)

Starfighters Space

Haoxin

Sidus Space

Mega Fortune

Jyong Biotech

Hycroft Mining

Velo3D

Tradr 2X Long QBTS Daily ETF

Creative Media & Community Trust

Tradr 2X Long FLY Daily ETF

ADMA生物制藥

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel制藥

OpGen

福泰制藥

再生元制藥

阿里拉姆制藥

Argenx

百濟神州

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap